| Mitochondrial dysfunction and mitophagy in Parkinson’s disease: from mechanism to therapy AB Malpartida, M Williamson, DP Narendra, R Wade-Martins, BJ Ryan Trends in biochemical sciences 46 (4), 329-343, 2021 | 390 | 2021 |
| Serotonin (5-HT) neuron-specific inactivation of Cadherin-13 impacts 5-HT system formation and cognitive function A Forero, HP Ku, AB Malpartida, S Wäldchen, J Alhama-Riba, C Kulka, ... Neuropharmacology 168, 108018, 2020 | 23 | 2020 |
| Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models MG Williamson, M Madureira, W McGuinness, R Heon-Roberts, ED Mock, ... Human Molecular Genetics 32 (18), 2808-2821, 2023 | 22 | 2023 |
| Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid L Winchester, I Barber, M Lawton, J Ash, B Liu, S Evetts, L Hopkins-Jones, ... Brain communications 5 (1), fcac343, 2023 | 22 | 2023 |
| Direct neuronal reprogramming of NDUFS4 patient cells identifies the unfolded protein response as a novel general reprogramming hurdle G Sonsalla, AB Malpartida, T Riedemann, M Gusic, E Rusha, G Bulli, ... Neuron 112 (7), 1117-1132. e9, 2024 | 9 | 2024 |
| An approach to the proposal of drug combination for cancer therapy using a pathway data connectivity approach R Miller, S Muraru, AB Malpartida, J Low, MP de Almeida, B van Engelen, ... | 1 | 2022 |
| Identification of a novel proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF L Winchester, M Lawton, I Barber, J Ash, B Liu, S Evetts, L Hopkins-Jones, ... medRxiv, 2021.12. 26.21268282, 2021 | 1 | 2021 |
| USP30 inhibition improves mitochondrial health through both PINK1-dependent and independent mechanisms MG Williamson, R Heon-Roberts, SNJ Franks, E Mock, HBL Jones, ... bioRxiv, 2025.02. 03.636341, 2025 | | 2025 |
| Differentiation of human Dopamine Neurons (DaNs) from induced pluripotent stem cells (iPSCs) AB Malpartida, MC Caiazza, R Wade-Martins, B Ryan, KML Cramb | | 2023 |
